Ausgabe 10/2020
Inhalt (20 Artikel)
Diabetes Therapy Podcast: ATTD Conference Highlights
Sufyan Hussain, Tim Street
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
David M. Williams, Marc Evans
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
David M. Williams, Marc Evans
Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
João P. Ferreira, Francisco Araújo, Jorge Dores, Lèlita Santos, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana S. Lages, João Conceição, Pedro A. Laires, João Pelicano-Romano, Sílvia Alão
Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)
Sujoy Ghosh, Mangesh Tiwaskar, Rajiv Chawla, Shalini Jaggi, Arthur Asirvatham, Vijay Panikar
The Correlation Between RDW, MPV and Weight Indices After Metabolic Surgery in Patients with Obesity and DM/IGR: Follow-Up Observation at 12 Months
Li Zhou, Shibo Lin, Fan Zhang, Yizhe Ma, Zhenzhen Fu, Yingyun Gong, Dandan Hu, Shuai Ma, Xuan Ye, Leihang Qian, Xiaomei Geng, Ningli Yang, Hui Liang, Hongwen Zhou
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
Mauro Ragonese, Monica Larosa, Stefania Angotti, Stefania Annese, Laura Cruciani, Michela Dainelli, Giuseppe Lucisano, Giuseppe Prosperini, Michele Sacco, Enrica Salomone, Caterina Saponara, Roberta Semprini, Maria Chiara Rossi, Antonio Nicolucci
Discontinuing Aspirin After Short Term Use Versus Continuous Use with a P2Y12 Inhibitor for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Meta-analysis
Qiang Wang, Keping Yang, Pravesh Kumar Bundhun
Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial
Li Wang, Xiangyang Liu, Wenjuan Yang, Jingbo Lai, Xinwen Yu, Jianrong Liu, Xiling Gao, Jie Ming, Kaiyan Ma, Jing Xu, Zhufang Tian, Qingzhen He, Qiuhe Ji
Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
Jian Kuang, Jiankun Zhu, Siying Liu, Quanmin Li
The Effects of Mobile-App-Based Low-Carbohydrate Dietary Guidance on Postprandial Hyperglycemia in Adults with Prediabetes
Xiaoyu Chen, Haihua Su, Daisuke Kunii, Kousuke Kudou, Yiyan Zhang, Ying Zhao, Dan Zhang, Yuanyuan Xing, Jiaqi Teng, Zhiqiang Nie, Xinxin Liu, Kaijun Niu, Yong Zhao, Qi Guo
Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
Thomas Wilke, Sabrina Mueller, Andreas Fuchs, Margit S. Kaltoft, Stefan Kipper, Malgorzata Cel
Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis
Jin Yang, Qing Tian, Yuexin Tang, Arvind K. Shah, Ruya Zhang, Guojuan Chen, Ye Zhang, Swapnil Rajpathak, Tianpei Hong
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
Kristina S. Boye, Hélène Sapin, Luis-Emilio García-Pérez, Myriam Rosilio, Marco Orsini Federici, Elke Heitmann, Heike Jung, Ulrich Aigner, Bruno Guerci, Francesco Giorgino, Kirsi Norrbacka
Decreased Muscle Strength of Knee Flexors is Associated with Impaired Muscle Insulin Sensitivity in Non-Diabetic Middle-Aged Japanese Male Subjects
Yuki Someya, Yoshifumi Tamura, Kageumi Takeno, Saori Kakehi, Takashi Funayama, Yasuhiko Furukawa, Hiroaki Eshima, Keisuke Watanabe, Toshiyuki Kurihara, Toshio Yanagiya, Hideyoshi Kaga, Ruriko Suzuki, Daisuke Sugimoto, Satoshi Kadowaki, Ryuzo Kawamori, Hirotaka Watada
Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial
Kelly N. B. Palmer, Valene E. Garr Barry, David G. Marrero, Brett M. McKinney, Anne N. Graves, Chelsy K. Winters, Tamara S. Hannon
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency
Annaswamy Raji, Zhi Jin Xu, Raymond L. H. Lam, Edward A. O’Neill, Keith D. Kaufman, Samuel S. Engel
GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression
Mei Qiu, Liang-Liang Ding, Miao Zhang, Jin-Hao Lin, Xu-Bin Wei, Hua Huang
Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”
Anne B. Brooks, Jakob Langer, Tommi Tervonen, Mads Peter Hemmingsen, Kosei Eguchi, Elizabeth D. Bacci